BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 24755310)

  • 1. A nationwide survey on Marinesco-Sjögren syndrome in Japan.
    Goto M; Okada M; Komaki H; Sugai K; Sasaki M; Noguchi S; Nonaka I; Nishino I; Hayashi YK
    Orphanet J Rare Dis; 2014 Apr; 9():58. PubMed ID: 24755310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of SIL1 Affects Actin Dynamics and Leads to Abnormal Neural Migration.
    Xu Y; Sun H; Chen J; Qin L; Wu M; Zhong Z; Zhang X
    Mol Neurobiol; 2024 Jun; ():. PubMed ID: 38850350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the enhanced ER stress response in Marinesco-Sjögren syndrome.
    Kashimada A; Hasegawa S; Isagai T; Uchiyama T; Matsuo M; Kawai M; Goto M; Morio T; Hayashi YK; Takagi M
    J Neurol Sci; 2018 Feb; 385():49-56. PubMed ID: 29406913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PERK inhibition delays neurodegeneration and improves motor function in a mouse model of Marinesco-Sjögren syndrome.
    Grande V; Ornaghi F; Comerio L; Restelli E; Masone A; Corbelli A; Tolomeo D; Capone V; Axten JM; Laping NJ; Fiordaliso F; Sallese M; Chiesa R
    Hum Mol Genet; 2018 Jul; 27(14):2477-2489. PubMed ID: 29718201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel SIL1 nonstop mutation in a Chinese consanguineous family with Marinesco-Sjögren syndrome and Dandy-Walker syndrome.
    Gai N; Jiang C; Zou YY; Zheng Y; Liang DS; Wu LQ
    Clin Chim Acta; 2016 Jul; 458():1-4. PubMed ID: 27106665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIL1-related Marinesco-Sjoegren syndrome (MSS) with associated motor neuronopathy and bradykinetic movement disorder.
    Byrne S; Dlamini N; Lumsden D; Pitt M; Zaharieva I; Muntoni F; King A; Robert L; Jungbluth H
    Neuromuscul Disord; 2015 Jul; 25(7):585-8. PubMed ID: 25958341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review: Protein misfolding diseases - the rare case of Marinesco-Sjögren syndrome.
    Chiesa R; Sallese M
    Neuropathol Appl Neurobiol; 2020 Jun; 46(4):323-343. PubMed ID: 31701543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Cellular Pathogenicity Markers for SIL1 Mutations Linked to Marinesco-Sjögren Syndrome.
    Gatz C; Hathazi D; Münchberg U; Buchkremer S; Labisch T; Munro B; Horvath R; Töpf A; Weis J; Roos A
    Front Neurol; 2019; 10():562. PubMed ID: 31258504
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel SIL1 mutations cause cerebellar ataxia and atrophy in a French-Canadian family.
    Noreau A; La Piana R; Marcoux C; ; Dion PA; Brais B; Bernard G; Rouleau GA
    Neurogenetics; 2015 Oct; 16(4):315-8. PubMed ID: 26260654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marinesco-Sjögren syndrome caused by a new SIL1 frameshift mutation.
    Cerami C; Tarantino P; Cupidi C; Annesi G; Lo Re V; Gagliardi M; Piccoli T; Quattrone A
    J Neurol Sci; 2015 Jul; 354(1-2):112-3. PubMed ID: 25982182
    [No Abstract]   [Full Text] [Related]  

  • 11. An Eye on Movement Disorders.
    Wilson D; Hallett M; Anderson T
    Mov Disord Clin Pract; 2021 Nov; 8(8):1168-1180. PubMed ID: 34765682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Role of SIL1 in Neurodevelopment and Learning.
    Xu S; Zhu J; Mi K; Shen Y; Zhang X
    Neural Plast; 2019; 2019():9653024. PubMed ID: 31531014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unexpected role for the yeast nucleotide exchange factor Sil1 as a reductant acting on the molecular chaperone BiP.
    Siegenthaler KD; Pareja KA; Wang J; Sevier CS
    Elife; 2017 Mar; 6():. PubMed ID: 28257000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel mutation in the proteolytic domain of LONP1 causes atypical CODAS syndrome.
    Inui T; Anzai M; Takezawa Y; Endo W; Kakisaka Y; Kikuchi A; Onuma A; Kure S; Nishino I; Ohba C; Saitsu H; Matsumoto N; Haginoya K
    J Hum Genet; 2017 Jun; 62(6):653-655. PubMed ID: 28148925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sil1-Mutant Mice Elucidate Chaperone Function in Neurological Disorders.
    Buchkremer S; González Coraspe JA; Weis J; Roos A
    J Neuromuscul Dis; 2016 May; 3(2):169-181. PubMed ID: 27854219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Zebrafish Models of Marinesco-Sjögren Syndrome.
    Kawahara G; Hayashi YK
    PLoS One; 2016; 11(10):e0165563. PubMed ID: 27792754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marinesco-Sjögren Syndrome in an Emirati Child with a Novel Mutation in SIL1 Affecting the 5' Untranslated Region.
    Nair P; Hamzeh AR; Mohamed M; Tawfiq N; Al-Ali MT; Bastaki F
    Med Princ Pract; 2016; 25(6):580-582. PubMed ID: 27544240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive Impairment and Brain Imaging Characteristics of Patients with Congenital Cataracts, Facial Dysmorphism, Neuropathy Syndrome.
    Chamova T; Zlatareva D; Raycheva M; Bichev S; Kalaydjieva L; Tournev I
    Behav Neurol; 2015; 2015():639539. PubMed ID: 26060356
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.